Handelsbanken Fonder
OCUL icon

Handelsbanken Fonder’s Ocular Therapeutix OCUL Stock Holding History

Handelsbanken Fonder’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$848K Buy
86,400
+17,100
+25% +$155K ﹤0.01% 1211
2026
Q1 		$587K Hold
69,300
– – ﹤0.01% 1251
2025
Q4 		$841K Buy
+69,300
New +$842K ﹤0.01% 1110

Other funds holding OCUL

DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return
ELI
Empire Life Investments Toronto, Ontario, Canada $1.79B AUM 38.49% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
EOJOAM
E. Ohman J:or Asset Management Stockholm, Sweden $4.3B AUM 29.55% 1-Year Est. Return
WB
WesBanco Bank Wheeling, West Virginia $4.02B AUM 32.62% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
KIA
Kraematon Investment Advisors Braintree, Massachusetts $134M AUM 29.42% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
CC
Courier Capital Buffalo, New York $2B AUM 24.36% 1-Year Est. Return

Handelsbanken Fonder's OCUL Position: Q2 2026 in Review

Handelsbanken Fonder increased its Ocular Therapeutix (OCUL) stake by 25% in Q2 2026, buying an estimated $155K and bringing the position to 86,400 shares worth $848K. The position accounts for ﹤0.01% of the portfolio, ranked #1211.

Handelsbanken Fonder first reported a position in OCUL in Q4 2025 and has held it in 3 quarters since. 46 funds tracked by Wall St. Rank hold OCUL as of Q2 2026.

  • Handelsbanken Fonder held 86,400 shares of Ocular Therapeutix worth $848K as of Q2 2026.
  • Handelsbanken Fonder bought 17,100 Ocular Therapeutix shares in Q2 2026, an estimated $155K.
  • Ocular Therapeutix made up ﹤0.01% of Handelsbanken Fonder's portfolio in Q2 2026, its #1211 holding.
  • Handelsbanken Fonder first reported a position in Ocular Therapeutix in Q4 2025 and has held it in 3 quarters since.
  • 46 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q2 2026.

Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.